New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra.
González-López
M A
MA
Martínez-Taboada
V M
VM
González-Vela
M C
MC
Fernández-Llaca
H
H
Val-Bernal
J F
JF
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects*; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1